Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Preschool Children

Allergy, Asthma & Clinical Immunology

Van Bever Hugo²  Lim Siok Hoon³  Chiang Wen Chin³  Liew Woei Kang³  Mona Iancovici Kidon¹ 

[1]Rheumatology, Immunology and Allergy Service, Department of Paediatric Medicine, KK Children's Hospital, Singapore

[2]Department of Paediatrics, National University Hospital, Singapore

[3]Department of Paediatric Medicine, KK Children's Hospital, Singapore

关键词: preschool;    NSAID;    ibuprofen;    hypersensitivity;    children;    acetylsalicylic acid (ASA);    acetaminophen;   

Others  :  1083818
DOI  :  10.1186/1710-1492-3-4-114

【 授权许可】

   
2007 Canadian Society of Allergy and Clinical Immunology

【 参考文献 】

• [1]Aspirin and Reye syndrome: Committee on Infectious Diseases. Pediatrics 1982, 69:810-2.
• [2]Drug and Device Approvals - March 1995 U.S. Food and Drug administration, Center for Drug Evaluation and Research; 1995.
• [3]Chandrasekharan NV, Dai H, Roos KL, et al.: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002, 99:13926-31.
• [4]Stevenson DD, Simon RA, Zuraw BL: Sensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs. In Adkinson: Middleton's Allergy, Principles and Practice. 6th edition. Edited by Elliott Middleton J, Charles E Reed, Elliot F Ellis, N Franklin Adkinson J, John W Yunginger, William W Busse. Mosby Inc; 2003:1695.
• [5]Settipane RA, Constantine HP, Settipane GA: Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980, 35:149-54.
• [6]Martinez-Mir I, Garcia-Lopez M, Palop V, et al.: A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996, 42:319-24.
• [7]Kidon MI, See Y: Adverse drug reactions in Singaporean children. Singapore Med J 2004, 45:574-7.
• [8]Titchen T, Cranswick N, Beggs S: Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br J Clin Pharmacol 2005, 59:718-23.
• [9]Vedanthan PK, Menon MM, Bell TD, Bergin D: Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma. J Allergy Clin Immunol 1977, 60:8-13.
• [10]Schuhl JF, Pereyra JG: Oral acetylsalicylic acid (aspirin) challenge in asthmatic children. Clin Allergy 1979, 9:83-8.
• [11]Rachelefsky GS, Coulson A, Siegel SC, Stiehm ER: Aspirin intolerance in chronic childhood asthma: Detected by oral challenge. Pediatrics 1975, 56:443-8.
• [12]Falliers CJ: Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol 1973, 52:141-7.
• [13]Capriles-Behrens E, Caplin J, Sanchez-Borges M: NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol 2000, 10:277-9.
• [14]Sanchez-Borges M, Capriles-Hulett A: Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000, 84:101-6.
• [15]Kidon MI, Kang LW, Chin CW, et al.: Early Presentation With Angioedema and Urticaria in Cross-reactive Hypersensitivity to Nonsteroidal Anti-inflammatory Drugs Among Young, Asian, Atopic Children. Pediatrics 2005.
• [16]Speer F, Denison TR, Baptist JE: Aspirin allergy. Ann Allergy 1981, 46:123-6.
• [17]Lesko SM, Mitchell AA: The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999, 104:e39.
• [18]Lesko SM, Louik C, Vezina RM, Mitchell AA: Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002, 109:E20.
• [19]Szczeklik A, Sladek K, Dworski R, et al.: Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996, 154:1608-14.
• [20]Cowburn AS, Sladek K, Soja J, et al.: Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998, 101:834-46.
• [21]Sanak M, Simon HU, Szczeklik A: Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997, 350:1599-600.
• [22]Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A: Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000, 23:290-6.
• [23]Yoshida S, Sakamoto H, Ishizaki Y, et al.: Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. Clin Exp Allergy 2000, 30:64-70.
• [24]Dahlen SE, Malmstrom K, Nizankowska E, et al.: Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002, 165:9-14.
• [25]Van Sambeek R, Stevenson DD, Baldasaro M, et al.: 5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000, 106:72-6.
• [26]Choi JH, Kim SH, Bae JS, et al.: Lack of an association between a newly identified promoter polymorphism (-1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population. Tohoku J Exp Med 2006, 208:49-56.
• [27]Oosaki R, Mizushima Y, Mita H, Shida T, Akiyama K, Kobayashi M: Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy 1997, 52:470-3.
• [28]Akahoshi M, Obara K, Hirota T, et al.: Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet 2005, 117:16-26.
• [29]Dekker JW, Nizankowska E, Schmitz-Schumann M, et al.: Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 1997, 27:574-7.
• [30]Choi JH, Lee KW, Oh HB, et al.: HLA association in aspirin-intolerant asthma: DPB1 * 0301 as a strong marker in a Korean population. J Allergy Clin Immunol 2004, 113:562-4.
• [31]Szczeklik A: Aspirin-induced asthma as a viral disease. Clin Allergy 1988, 18:15-20.
• [32]Tan Y, Collins-Williams C: Aspirin-induced asthma in children. Ann Allergy 1982, 48:1-5.
• [33]Kauppinen K, Juntunen K, Lanki H: Urticaria in children. Retrospective evaluation and follow-up. Allergy 1984, 39:469-72.
• [34]Legrain V, Taieb A, Sage T, Maleville J: Urticaria in infants: a study of forty patients. Pediatr Dermatol 1990, 7:101-7.
• [35]Moore-Robinson M, Warin RP: Effect of salicylates in urticaria. Br Med J 1967, 4:262-4.
• [36]Wright AL, Minford A: Urticaria and hidden salicylates. Pediatr Dermatol 1999, 16:463-4.
• [37]Botey J, Ibero M, Malet A, et al.: Aspirin-induced recurrent urticaria and recurrent angioedema in non-atopic children. Ann Allergy 1984, 53:265-7.
• [38]Diaz JM, Perez MA, Gracia Bara MT, et al.: Allergic reactions due to ibuprofen in children. Pediatr Dermatol 2001, 18:66-7.
• [39]de Almeida MA, Gaspar AP, Carvalho FS, et al.: Adverse reactions to acetaminophen, ASA, and NSAIDs in children: what alternatives. Allergy Asthma Proc 1997, 18:313-8.
• [40]Botey J, Navarro C, Aulesa C, et al.: Acetyl salicylic acid inducedurticaria and/or angioedema in atopic children. Allergol Immunopathol (Madr) 1988, 16:43-7.
• [41]Kidon MI, Abramovitch I, Steinberg S, et al.: Cross reactive hypersensitivity to COX inhibitors in a child with mild Allergic Rhinitis, a case report. IMAJ 2005, in press.
• [42]Goraya JS, Virdi VS: To the editor: Exacerbation of asthma by ibuprofen in a very young child. Pediatr Pulmonol 2001, 32:262.
• [43]Sehgal VN: Paracetamol-induced bilateral symmetric, multiple fixed drug eruption (MFDE) in a child. Pediatr Dermatol 1999, 16:165-6.
• [44]Halevi A, Ben Amitai D, Garty BZ: Toxic epidermal necrolysis associated with acetaminophen ingestion. Ann Pharmacother 2000, 34:32-4.
• [45]Dogra S, Handa S: Bullous necrotizing fixed drug eruption in an infant. Pediatr Dermatol 2004, 21:281-2.
• [46]Kanwar AJ, Bharija SC, Belhaj MS: Fixed drug eruptions in children: a series of 23 cases with provocative tests. Dermatologica 1986, 172:315-8.
• [47]Aberer W, Bircher A, Romano A, et al.: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58:854-63.
• [48]Asero R: Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003, 111:1095-8.
• [49]Boussetta K, Ponvert C, Karila C, et al.: Hypersensitivity reactions to paracetamol in children: a study of 25 cases. Allergy 2005, 60:1174-7.
• [50]Pastorello EA, Zara C, Riario-Sforza GG, et al.: Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 1998, 53:880-4.
• [51]Gyllfors P, Bochenek G, Overholt J, et al.: Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003, 111:1116-21.
• [52]Sanchez BM, Capriles-Hulett A, Caballero-Fonseca F, Perez CR: Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001, 87:201-4.
• [53]Debley JS, Carter ER, Gibson RL, et al.: The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. J Pediatr 2005, 147:233-8.
• [54]Gray PA, Warner TD, Vojnovic I, et al.: Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Br J Pharmacol 2002, 137:1031-8.
• [55]Dahlen B, Szczeklik A, Murray JJ: Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. N Engl J Med 2001, 344:142.
• [56]Garcia-Rodriguez RM, Hinojosa M, Camacho-Garrido E, et al.: Celecoxib, safe in NSAID intolerance. Allergy 2002, 57:1085-6.